Login to Your Account



Transatlantic VC Fund Takes Aim at Rare Disease Space

By Nuala Moran
Staff Writer

Wednesday, June 26, 2013
LONDON – European and U.S. investors are joining forces to launch the first venture capital fund dedicated solely to investing in treatments for rare diseases.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription